BW
VRDN icon

Biegel & Waller’s Viridian Therapeutics VRDN Stock Holding History

Biegel & Waller’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$49K Hold
4,434
– – 0.03% 71
2019
Q2 		$136K Hold
4,434
– – 0.07% 76
2019
Q1 		$186K Hold
4,434
– – 0.1% 73
2018
Q4 		$202K Hold
4,434
– – 0.12% 67
2018
Q3 		$371K Hold
4,434
– – 0.21% 42
2018
Q2 		$426K Hold
4,434
– – 0.27% 35
2018
Q1 		$466K Hold
4,434
– – 0.3% 26
2017
Q4 		$694K Hold
4,434
– – 0.4% 20
2017
Q3 		$609K Buy
+4,434
New +$746K 0.38% 21

Other funds holding VRDN

AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return